Exact Mass: 502.0384
Exact Mass Matches: 502.0384
Found 34 metabolites which its exact mass value is equals to given mass value 502.0384,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1,3-Benzodithiol-2-yltriphenyl phosphonium tetrafluoroborate
1,3-Benzodithiol-2-yltriphenyl phosphonium tetrafluoroborate
cis-Bis(2,2‘-bipyridine)dichlororuthenium(II) hydrate
cis-Bis(2,2‘-bipyridine)dichlororuthenium(II) hydrate
3-[acetyl(hydroxy)amino]propyl-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyphosphinic acid
3-[acetyl(hydroxy)amino]propyl-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyphosphinic acid
4-Chloro-3-(trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
4-Chloro-3-(trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
4-[4-[(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]-2-hydroxybenzoic acid
4-[4-[(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]-2-hydroxybenzoic acid
beta-D-Galp3S-(1->4)-beta-D-Glcp6S
beta-D-Galp3S-(1->4)-beta-D-Glcp6S
A glycosylglucose derivative that is beta-lactose bearing two sulfo substituents at position 3 of the galactosyl residue and position 6 of the glucose.
beta-D-Galp6S-(1->4)-beta-D-Glcp6S
beta-D-Galp6S-(1->4)-beta-D-Glcp6S
A glycosylglucose derivative that consists of 6-sulfated beta-D-glucose having a 6-sulfated beta-D-galactosyl residue attached at position 4.
6-Azauridine triphosphate (ammonium)
6-Azauridine triphosphate (ammonium)
6-Azauridine triphosphate ammonium (6-Azauridine 5′-triphosphate ammonium) is a nucleotide analog similar to uridine triphosphate, which can be used to study the mechanism of RNA synthesis and transcription regulation[1].
SMS1-IN-1
SMS1-IN-1
SMS1-IN-1, compound SAPA 1j, is a novel and the most potent sphingomyelin synthase 1 (SMS1) inhibitor with an IC50 value of 2.1 μM. SMS1-IN-1 has the potential for the treatment of atherosclerosis[1].
2,3,5,6,8-pentahydroxy-7-[1-(1,3,4,6,7-pentahydroxy-5,8-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione
2,3,5,6,8-pentahydroxy-7-[1-(1,3,4,6,7-pentahydroxy-5,8-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione
16-chloro-17-(chloromethyl)-4,10-dihydroxy-6,15-dimethoxy-6-methyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,17,19-octaene-2,8,12-trione
16-chloro-17-(chloromethyl)-4,10-dihydroxy-6,15-dimethoxy-6-methyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,17,19-octaene-2,8,12-trione
7,9,13,20,24,26-hexahydroxynonacyclo[16.12.0.0²,¹⁵.0³,¹².0⁴,²⁹.0⁵,¹⁰.0⁶,²⁷.0²¹,³⁰.0²³,²⁸]triaconta-1(18),2,4(29),5(10),6,8,12,14,19,21(30),23,25,27-tridecaene-11,22-dione
7,9,13,20,24,26-hexahydroxynonacyclo[16.12.0.0²,¹⁵.0³,¹².0⁴,²⁹.0⁵,¹⁰.0⁶,²⁷.0²¹,³⁰.0²³,²⁸]triaconta-1(18),2,4(29),5(10),6,8,12,14,19,21(30),23,25,27-tridecaene-11,22-dione
4-bromo-2-{2-[3-bromo-6-(2-chloro-1-hydroxyethyl)-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol
4-bromo-2-{2-[3-bromo-6-(2-chloro-1-hydroxyethyl)-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol
[(1s)-2-(3,5-dibromo-4-methoxyphenyl)-1-{[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl]trimethylazanium
[(1s)-2-(3,5-dibromo-4-methoxyphenyl)-1-{[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl]trimethylazanium
2,5,6,7,8-pentahydroxy-3-[1-(3,5,6,7,8-pentahydroxy-1,4-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione
2,5,6,7,8-pentahydroxy-3-[1-(3,5,6,7,8-pentahydroxy-1,4-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione
(2-{4-[3-(dimethylamino)propoxy]-3,5-diiodophenyl}ethyl)dimethylamine
(2-{4-[3-(dimethylamino)propoxy]-3,5-diiodophenyl}ethyl)dimethylamine
10,23-dichloro-16-methoxyhexacyclo[13.9.3.1²,⁶.0⁹,¹⁴.0¹⁸,²⁶.0²¹,²⁵]octacosa-1(24),2(28),3,5,9,11,13,15(27),16,18(26),19,21(25),22-tridecaene-3,13,24-triol
10,23-dichloro-16-methoxyhexacyclo[13.9.3.1²,⁶.0⁹,¹⁴.0¹⁸,²⁶.0²¹,²⁵]octacosa-1(24),2(28),3,5,9,11,13,15(27),16,18(26),19,21(25),22-tridecaene-3,13,24-triol
3,4,5-trihydroxy-2-({5,7,12,13,14-pentahydroxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-6-yl}oxy)benzoic acid
3,4,5-trihydroxy-2-({5,7,12,13,14-pentahydroxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-6-yl}oxy)benzoic acid
(1r,2r,4r)-4-bromo-2-{2-[(2s,3r,6s)-3-bromo-6-[(1s)-2-chloro-1-hydroxyethyl]-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol
(1r,2r,4r)-4-bromo-2-{2-[(2s,3r,6s)-3-bromo-6-[(1s)-2-chloro-1-hydroxyethyl]-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol
